Next Article in Journal
Sucrosomial Iron Supplementation in Anemic Patients with Celiac Disease Not Tolerating Oral Ferrous Sulfate: A Prospective Study
Next Article in Special Issue
Effects of Polyphenol-Rich Foods on Human Health
Previous Article in Journal
20(S)-Ginsenoside Rh2 Induce the Apoptosis and Autophagy in U937 and K562 Cells
Previous Article in Special Issue
Dietary Inflammatory Index and Cardiovascular Risk and Mortality—A Meta-Analysis
Open AccessArticle

Resveratrol in Patients with Minimal Hepatic Encephalopathy

1
Research Center “The Great Senescence”, University of Catania, 95126 Catania, Italy
2
Department of Biomedical and Biotechnological Science, University of Catania, 95123 Catania, Italy
3
Spinal Unit of Cannizzaro Hospital, University of Catania, 95100 Catania, Italy
4
Department of Experimental and Clinical Medicine, University of Catania, 95123 Catania, Italy
5
Department “G.F. Ingrassia”, Section of Neurosciences, University of Catania, 95123 Catania, Italy
*
Author to whom correspondence should be addressed.
Nutrients 2018, 10(3), 329; https://doi.org/10.3390/nu10030329
Received: 15 December 2017 / Revised: 6 March 2018 / Accepted: 7 March 2018 / Published: 9 March 2018
(This article belongs to the Special Issue Effects of Polyphenol-Rich Foods on Human Health)
Background: Minimal Hepatic Encephalopathy (MHE) is characterized by an impairment of social interaction, emotional behavior, sleep disorders, physical and mental symptoms, and diminished Quality of Life (QoL). The aim of our study is evaluating the potential liver health promoting a perspective of Resveratrol (RV) activities and evaluate whether RV treatment may improve health related quality of life (HRQL) and reduce depression and anxiety in patients with MHE. Methods: We evaluated depression using the Beck Depression Inventory test, anxiety with State-trait anxiety inventory test, quality of life through SF-36 test, and ammonia serum levels in 70 MHE patients that were randomized into two groups. Results: In the comparison between RV group and placebo group we observed a decrease in Back Depression Inventory (BDI) (p < 0.001), in State-trait anxiety inventory (STAI) (p < 0.001), and improve in physical function (p < 0.001), in role physical (p < 0.05), in body pain (p < 0.05), in general health (p < 0.001), in vitality (p < 0.05), and in social function (p < 0.001). Conclusions: Resveratrol showed efficacy in the treatment of depression, anxiety, and ammonia serum levels, and improved the quality of life Of MHE patients. View Full-Text
Keywords: depression; anxiety; resveratrol; ammonia; quality of life; minimal hepatic encephalopathy depression; anxiety; resveratrol; ammonia; quality of life; minimal hepatic encephalopathy
Show Figures

Figure 1

MDPI and ACS Style

Malaguarnera, G.; Pennisi, M.; Bertino, G.; Motta, M.; Borzì, A.M.; Vicari, E.; Bella, R.; Drago, F.; Malaguarnera, M. Resveratrol in Patients with Minimal Hepatic Encephalopathy. Nutrients 2018, 10, 329.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop